港股药明合联（02268）今日盘中出现意外大跌，截至上午10时18分，跌幅达5.12%，引发市场关注。这一跌势与该公司昨日发布的强劲中期业绩形成鲜明对比。
根据药明合联8月18日发布的2025年中期业绩报告，公司上半年实现营收27.01亿元人民币，同比大幅增长62.2%；归属于公司股东的净利润为7.46亿元，同比增长52.74%；每股基本盈利0.62元，同比增长51.22%。这些数据均显示出公司业务的强劲增长势头。
然而，尽管业绩表现亮眼，药明合联的股价却出现大幅下跌。分析人士认为，这可能是由于投资者对公司未来增长预期的调整，或是出于获利了结的考虑。此外，公司宣布不派发中期股息，这也可能影响了部分投资者的持股意愿。值得注意的是，整体市场情绪也可能对个股表现产生影响。投资者需密切关注后续市场动向及公司公告，以更全面地评估药明合联的投资价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.